Not logged inThreshold ratio of stent-to-vessel diameter related to in-stent stenosis after flow diverter treatment of intracranial aneurysm
Gao, Jieyu; Zhang, Qianqian; Lv, Nan; Li, Qiang; Gu, Yuxiang; Xu, Liquan; Huang, Chuangren; Mao, Guohua; Lu, Hua; Zhong, Shu; Duan, Chuanzhi; Xie, Xiaodong; Wan, Jieqing; Wang, Feng; Guan, Sheng; Shao, Qiuji; Chang, Kaitao; Ding, Jinyi; Lei, Yingbo; Li, Tianxiao; Lv, Ming; Li, Li; Liu, Jianmin .png)
Share.png)
SaveEfficacy and safety of finotonlimab plus docetaxel vs. docetaxel in previously treated advanced squamous cell non-small-cell lung cancer: a randomized, double-blinded, phase III trialHan, Baohui; Wu, Lin; Yang, Runxiang; Wu, Hongbo; Li, Wei; Yu, Yan; Zhang, Mingjuan; Sun, Hongmei; Chu, Tianqing; Zhong, Fukuan; Fang, Yong; Wu, Rong; Bian, Tao; Guo, Xiaoqing; Sun, Meili; Zhang, Yanming; Liu, Lianke; Liu, Xuewen; Pan, Yueyin; Jiang, Ou; Wei, Zonghui; Lin, Haifeng; Guo, Wei; Fang, Jian; Wang, Jialei; Ding, Cuimin; Hu, Yanping; Ye, Feng; Zhuang, Wu; Ye, Shucheng; Wang, Lihong; Huang, Zhe; Liu, Chang; Yang, Ling; Wang, Jinling; Xie, Liangzhi Share Save Share Save The preliminary multicenter retrospective study on the efficacy and safety of thermal ablation for follicular thyroid neoplasms ≤ 3 cmLiu, Yu-tong; Fan, Bo-Qiang; He, Jun-feng; Zhou, Ying; Wu, Song-song; Wang, Shu-rong; Dong, Gang; Guo, Jian-qin; Wei, Ying; Zhao, Zhen-Long; Wu, Jie; Cao, Shi-Liang; Yu, Na; Li, Yan; Peng, Li-Li; Yu, Ming-an Share Save Efficacy and Safety of Efdamrofusp Alfa versus Aflibercept in Participants with Neovascular Age-Related Macular Degeneration A Randomized, Double-Masked, Active-Controlled, Noninferiority, Phase II TrialSun, Junran; Song, Yanping; Gong, Yuanyuan; Tao, Liming; Wang, Hong; Shu, Xiangwen; Wen, Ying; Cui, Ling; Ye, Jian; Lu, Shujie; Deng, Junjie; Li, Haoyu; Xu, Yihua; Qian, Lei; Wu, Zhifeng; Bi, Yanlong; Liu, Qinghuai; Xu, Xiangzhong; Wu, Miaoqin; Zhang, Jinglin; Hao, Jilong; Tong, Jianping; Dai, Hong; Wang, Feng; Zhao, Mingwei; Mao, Junfeng; Li, Chaopeng; He, Tao; Pei, Cheng; Liu, Xiaoling; Wang, Xian; Li, Mingxin; Wang, Wei; Zheng, Qinxiang; Guan, Huaijin; Peng, Hui; Fan, Ke; Zhang, Wenfang; Zhu, Dan; Yu, Songping; Wei, Wenbin; Ding, Lin; Li, Jinying; Lu, Peirong; Yan, Ming; Liu, Wei; Jia, Huixun; Sun, Xiaodong Share Save Irinotecan liposome-based regimen in Chinese patients with advanced pancreatic cancer: A prospective, multi-center, observational real-world studyXu, J.; Jiang, K.; Lu, H.; Gong, X.; Li, H.; Wu, Y.; Chen, L.; Liu, W.; Wu, D.; Du, J.; Sun, L.; Zhao, Y.; Dai, E.; An, H.; Liu, Y.; Wang, X.; Liu, Q.; Yu, X. Share Save Share Save Weekly Selinexor, Bortizomib and Dexamethasone (SVd) Versus Twice Weekly Bortizomib and Dexamethasone (Vd) in Chinese Patients with Relapsed and Refractory Multiple Myeloma (RRMM): Primary Analysis of Phase 3 Bench StudyLu, Jin; Geng, Liangquan; Chen, Lijuan; Liu, Peng; Zhong, Yuping; Liu, Zhuogang; Xia, Zhongjun; Mi, Jianqing; Li, Chunrui; Zhang, Xi; He, Yanjuan; Wei, Yongqiang; Fang, Baijun; Li, Fei; Cai, Zhen; Wang, Yafei; Huang, Dongping; Liu, Hong; Hou, Ming; Fu, Rong; Du, Xin; Fang, Xiaosheng; Zeng, Qingshu; Gao, Wen; Wang, Wei; Chang, Chunkang; Ouyang, Guifang; Liu, Jing; Weng, Jianyu; Huang, Xiaobing; Yu, Yang; Guo, Zhi; Zhao, Jun; Hou, Jian Share Save A Phase 2 Study of Olverembatinib for the Treatment of Myeloid/Lymphoid Neoplasms with FGFR1 RearrangementChen, Suning; Wu, Depei; Cai, Wenzhi; Dou, Xueqing; Liu, Zhenfang; Zhu, Yu; Wang, Ying; Yang, Chunmei; Hu, Jiong; Miao, Miao; Deng, Xiuzhi; Chen, Chunyan Share Save Phase III Randomized COMMODORE 2 Trial: 2-Year Efficacy and Safety of Crovalimab in Patients with Paroxysmal Nocturnal Hemoglobinuria (PNH) Naive to Complement InhibitionRoeth, Alexander; He, Guangsheng; Brodsky, Andres; Chai-Adisaksopha, Chatree; Comia, Narcisa Sonia; Gaya, Anna; Hoeglund, Martin; Kelly, Richard J.; Kori, Ahlam Naila; Lee, Je-Hwan; Obara, Naoshi; Risitano, Antonio M.; Appius, Anita; Beveridge, Leigh; Gentile, Brittany; Zhang, Zilu; Han, Bing; Sreckovic, Sasha Share Save Share Save Share Save Deucravacitinib, an oral selective allosteric tyrosine kinase 2 inhibitor, in patients from China mainland, Taiwan and South Korea with moderate-to-severe plaque psoriasis: a phase III randomized clinical trialZhang, Jianzhong; Ding, Yangfeng; Wang, Ping; Li, Linfeng; Pan, Weili; Lu, Yan; Cheng, Hao; Jiang, Xian; Ho, Ji-Chen; Guo, Shuping; Liu, Leona; Chatterjee, Arkendu; Kisa, Renata M.; Banerjee, Subhashis Share Save DVDMS (Sinoporphyrin sodium)-mediated photodynamic therapy (PDT) vs treatment of physician's choice in patients with advanced esophageal cancer (EC): Preliminary results of DYNA-Esophagus03, a randomized, open-labeled, multicenter phase IIIb studyZhou, J.; Gao, S. G.; Xing, L.; Liu, J.; Wang, J.; Shu, Y.; Tuo, B.; Cui, L.; Wan, L.; Bai, W.; Zhao, J.; Ning, F.; Ji, Y.; Xia, B.; Jiang, X.; Li, L.; Xu, G.; Lu, Z.; Zhang, S.; Shen, L. Share Save IBI354 (anti-HER2 antibody-drug conjugate [ADC]) in patients (pts) with advanced gynecological cancers (Gynecol C): Results from a phase I studyShu, J.; Zhu, T.; Huang, Y.; Xu, Q.; Guo, R.; Liu, H.; Zhao, H.; Zhu, L.; Wang, X.; Xu, X.; Cheng, W.; Tang, J.; Zhu, Q.; Chen, X.; An, R.; Gao, J.; Li, G.; Zhang, Z.; Zhou, H.; Zhou, Q. Share Save Exploratory analysis of patients with or without prior PD-(L) 1 inhibitors in phase III OptiTROP-Breast01 study of sacituzumab tirumotecan (sac-TMT) versus chemotherapy for previously treated advanced triple-negative breast cancer (TNBC)Yin, Y.; Fan, Y.; Ouyang, Q.; Song, L.; Wang, X.; Li, W.; Li, M.; Yan, X.; Wang, S.; Sun, T.; Teng, Y.; Tang, X.; Tong, Z.; Sun, Z.; Jin, X.; Diao, Y.; Liu, G.; Ge, J.; Xu, B. Share Save Share Save Share Save 
.png){kind=icon}
.png){kind=icon}
.png){kind=icon}
.png){kind=icon}
.png){kind=icon}
